TICKVALE
>⌘K
NYSE · CIK 0000070318 · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC

TENET HEALTHCARE CORP

THC chart by TradingView
P/E 4.9xP/B 3.4xP/SALES 0.7xEV/EBITDA FCF YIELD 19.24%

PRICE HISTORY

LIVE · NYSE
THC chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$21.3B
EBITDA
$4.4B
FREE CASH FLOW
$2.5B
EPS
$26.06
GROSS MARGIN
ROIC
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

4.9x
-66%
LATEST · Q2 FY26
4.9xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.0x23.0x

P / SALES (TTM)

0.7x
+579%
LATEST · Q2 FY26
0.7xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.1x0.9x

P / BOOK

3.4x
-21%
LATEST · Q2 FY26
3.4xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.9x150.1x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

FCF YIELD (TTM)

19.24%
+12.5pp
LATEST · Q2 FY26
19.24%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-22.25%140.43%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$5.6B
+8%
LATEST · Q2 FY26
5.6BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$1.7B
+215%
LATEST · Q2 FY26
1.7BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$1.0B
+1206%
LATEST · Q2 FY26
1.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$12.45
+1448%
LATEST · Q2 FY26
12.45Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

6.77%
+3.8pp
LATEST · Q2 FY26
6.77%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-20.00%35.80%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

7.41%
+6.1pp
LATEST · Q2 FY26
7.41%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-13.03%58.47%

RETURN ON CAPITAL

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

RETURN ON EQUITY (TTM)

68.14%
+38.8pp
LATEST · Q2 FY26
68.14%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-825.00%2742.86%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN
OPERATING MARGIN26.67%
NET MARGIN18.57%
FCF MARGIN7.41%
68.6246.3524.081.82-20.45OPERNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$0.4B
+513%
LATEST · Q2 FY26
0.4BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.0B
+175%
LATEST · Q2 FY26
0.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.2B
-16%
LATEST · Q2 FY26
0.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.08B
-16%
LATEST · Q2 FY26
0.08BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$2.2B
+234%
LATEST · Q2 FY26
2.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 106.35%INSIDERS 1.14%OTHER / RETAIL 0.00%907 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.10.81%8.7M$2.28B+2.0%
FMR, LLC9.66%7.8M$2.04B+1.8%
Price (T.Rowe) Associates Inc9.34%7.5M$1.97B+0.4%
Boston Partners5.51%4.4M$1.16B+15.6%
Vanguard Portfolio Management LLC5.36%4.3M$1.13BNEW
Vanguard Capital Management LLC4.86%3.9M$1.03BNEW
State Street Corporation3.37%2.7M$711.9M+0.8%
Wellington Management Group, LLP2.91%2.3M$614.7M+106.5%
Lone Pine Capital Llc2.81%2.3M$592.1M+26.4%
Geode Capital Management, LLC2.40%1.9M$506.0M+12.0%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.